Papers

3

Total Citations

51

H-Index

2

About

Shankar Siva is a leading radiation oncologist whose research is reshaping the treatment of thoracic and genitourinary cancers, with a particular focus on stereotactic ablative radiotherapy (SABR). His most cited work, "Lung Cancer in Australia" (2020, 39 citations), provides a critical epidemiological overview of the disease, underscoring his commitment to improving outcomes on a national scale. Siva is widely recognized for his technical expertise in SABR, as detailed in his influential paper "Technical know‐how in stereotactic ablative radiotherapy" (2016, 10 citations), where he emphasizes the stringent requirements and narrow therapeutic window of this precise technique. His contributions extend to urological oncology, notably addressing the clinical dilemma of incidental small renal masses in solitary kidneys (2025, 2 citations), offering nuanced guidance for balancing curative surgery with organ preservation. Through his work, Siva has advanced the safe and effective delivery of high-dose radiation, bridging technical rigor with clinical application. His research continues to inform best practices in cancer care, making him a key figure in the evolution of modern radiotherapy.

Research Focus

Key Achievements

2
H-Index
3
Papers
51
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Lung Cancer in Australia
39 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: Peter MacCallum Cancer Centre, University of Melbourne

Top Papers

  1. 1
    Lung Cancer in Australia
    39 citations · 2020
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago